O36.093
Maternal care for other rhesus isoimmunization, third trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Rhesus isoimmunization is a condition that can occur during pregnancy when a Rh-negative mother is carrying a Rh-positive baby. This incompatibility causes the mother's immune system to produce antibodies against the baby's red blood cells, which can lead to hemolytic disease of the fetus or newborn (HDFN). The ICD-10 code O36.093 specifically refers to maternal care for this condition during the third trimester, emphasizing ongoing management to monitor and address potential complications. Understanding and managing rhesus isoimmunization during pregnancy is critical to ensure the health and safety of both mother and baby. In the third trimester, careful assessment allows healthcare providers to take necessary steps to prevent severe fetal anemia, jaundice, or other related complications.
Causes & Symptoms
Clinical Causes: Mother has Rh-negative blood type Baby has Rh-positive blood type Previous pregnancy with Rh-positive baby Blood transfusions involving Rh-positive blood Fetal-maternal hemorrhage, especially during delivery or invasive prenatal procedures
Key Symptoms: No symptoms in the mother; most cases are detected through screening Signs of fetal anemia or jaundice in the fetus or newborn Fetal hydrops (severe swelling and fluid accumulation) Reduced fetal movement Increased levels of bilirubin, leading to jaundice after birth
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves several steps to assess the risk and presence of Rhesus isoimmunization: - Blood tests to determine the Rh status of both mother and fetus - Amniocentesis to measure bilirubin levels in the amniotic fluid - Ultrasound scans to detect signs of fetal anemia or hydrops - Doppler ultrasonography to evaluate blood flow in the fetal brain (middle cerebral artery) as an indicator of anemia - Maternal antibody titers to measure the level of Rh antibodies in the mother's blood Regular monitoring and testing are essential during the third trimester to track the condition's progression and guide management decisions.
Treatment Protocols: Management of Rhesus isoimmunization during the third trimester focuses on monitoring and intervention: - Administering Rh immunoglobulin (RhIg) to Rh-negative mothers at specified intervals to prevent the formation of new antibodies - Close fetal surveillance through ultrasound and Doppler studies to assess for signs of anemia or hydrops - Early delivery if fetal conditions worsen, to prevent severe complications - In certain cases, intrauterine blood transfusions may be performed to treat fetal anemia - Postnatal care involves treating jaundice or anemia in the newborn, often with phototherapy or transfusions Healthcare providers tailor management plans based on the severity of the condition and fetal well-being, aiming to optimize outcomes for both mother and child.
Clinical Advice & FAQs
Billing Guidance
Is O36.093 a billable ICD-10 code?
Yes, O36.093 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.093?
Clinical documentation must specify the nature of Maternal care for other rhesus isoimmunization, third trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference